Genomic data management and bioinformatics platforms
Strategic Profile
DNAnexus has raised $473M in funding from investors like Google Ventures, TPG and First Round Capital, with its most recent major financing being a Series H round for $200M in March 2022 led by Blackstone. The company ranks 2nd among 355 active competitors and 2nd in terms of total funding among its peers, positioning it as a well-capitalized leader in biomedical data infrastructure for the life sciences industry.
Cyborg Score Rationale
DNAnexus combines deep technical expertise in genomics informatics with substantial institutional capital ($666M+ raised from tier-one investors including Blackstone, Google Ventures, and pharmaceutical companies like Regeneron). The company operates in a high-growth market segment addressing genuine data infrastructure gaps in precision medicine and drug discovery, with strong customer validation from leading pharmaceutical and diagnostics firms.
Top Insights
DNAnexus has secured $666M in total funding over 11 rounds as of mid-2026, demonstrating sustained institutional confidence in its platform. The majority of the company's capitalization came from the March 2022 Series H round, indicating the market recognizes DNAnexus as a critical infrastructure layer for the genomics economy.
The platform operates as a secure, collaborative environment enabling pharmaceutical, diagnostic, and research organizations to manage multi-omics and clinical data using AI/ML-powered analytics. This positions DNAnexus at the intersection of healthcare IT and advanced analytics—markets experiencing 15-20% annual growth.
As of April 2026, DNAnexus employed 277 staff, indicating disciplined headcount management relative to capital raised. With latest funding occurring in March 2022, the company appears to be operating profitably or near cash-flow breakeven, a positive signal for long-term viability in a competitive biotech software landscape.
Named Competitors
Benchling — Cloud-based laboratory informatics and genomics platform
Golden Helix — Genomic analysis and visualization software
Congenica — Genomic analysis and interpretation platform
Latch — Bioinformatics workflow and data management platform
Recent Developments
(April 2026) Employee count reached 277 as of latest count
(March 2022) Series H funding round closed for $200M led by Blackstone Growth
(2025-2026) Strategic partnerships announced with Fore Genomics and Alida Bio for enhanced genomics research and RNA analysis capabilities
Open the full interactive DNAnexus, Inc. report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.